Evidence map›Paper›PMID 32752200›Full record

ArticleBiomolecules2020

Heparin Administered to

Elena Lantero, Jessica Fernandes, Carlos Raúl Aláez-Versón, Joana Gomes, Henrique Silveira, Fatima Nogueira, Xavier Fernàndez-Busquets

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Integrated Omics Reveal the Pathogenic Potential ofTransboundary and emerging diseases · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Elena LanteroInstitute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, ES-08028 Barcelona, Spain.
Jessica FernandesGlobal Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT-NOVA), Rua da Junqueira 100, 1349-008 Lisbon, Portugal.
Carlos Raúl Aláez-VersónBIOIBERICA S.A.U., Polígon Industrial "Mas Puigvert", Ctra. N-II, km. 680.6, ES-08389 Palafolls, Spain.
Joana GomesGlobal Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT-NOVA), Rua da Junqueira 100, 1349-008 Lisbon, Portugal.
Henrique SilveiraGlobal Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT-NOVA), Rua da Junqueira 100, 1349-008 Lisbon, Portugal.ORCID 0000-0002-7939-772X
Fatima NogueiraGlobal Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT-NOVA), Rua da Junqueira 100, 1349-008 Lisbon, Portugal.ORCID 0000-0003-0313-0778
Xavier Fernàndez-BusquetsInstitute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, ES-08028 Barcelona, Spain.ORCID 0000-0002-4622-9631
Universidade Nova de Lisboa · PTInstitute for Bioengineering of Catalonia · ES

Funding

BIOIBERICA Research AgreementERA-NET Cofund EURONANOMED (http://euronanomed.net/) 2017-178 (NANOpheles)Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (https://ghtm.ihmt.unl.pt/) UID/Multi/04413/2013Spanish Ministry of Science, Innovation and Universities (http://www.ciencia.gob.es/) PCIN-2017-100Spanish Ministry of Science, Innovation and Universities (http://www.ciencia.gob.es/) RTI2018-094579-B-I00
6 · The paper itself

Abstract

Innovative antimalarial strategies are urgently needed given the alarming evolution of resistance to every single drug developed against

Indexed as

AnimalsAnophelesAntimalarialsDietFemaleHeparinMalariaMiceMosquito VectorsOocystsPlasmodium bergheiZygoteAntimalarialsHeparinAnophelesantimalarial drugsheparinmalariamosquitoookinetePlasmodiumtransmission blocking

Identifiers

PMID32752200
PMCPMC7463908
OpenAlexW3046341388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.